Abstract:Extracellular vesicles (EV) can carry proteins, RNA and DNA, thus serving as communication tools between cells. Tumor cells secrete EV, which can be taken up by surrounding cells in the tumor microenvironment as well as by cells in distant organs. Tumor-derived EV (TEV) contain factors induced by tumor-associated hypoxia such as heat shock proteins or a variety of microRNA (miRNA). The interaction of TEV with tumor and host cells can promote cancer angiogenesis, invasion and metastasis. Myeloid cells are widely presented in tissues, comprise the majority of immune cells and play an essential role in immune reactions and tissue remodeling. However, in cancer, the differentiation of myeloid cells and their functions are impaired, resulting in tumor promotion. Such alterations are due to chronic inflammatory conditions associated with cancer and are mediated by the tumor secretome, including TEV. A high capacity of myeloid cells to clear EV from circulation put them in the central position in EV-mediated formation of pre-metastatic niches. The exposure of myeloid cells to TEV could trigger numerous signaling pathways. Progenitors of myeloid cells alter their differentiation upon the contact with TEV, resulting in the generation of myeloid-derived suppressor cells (MDSC), inhibiting anti-tumor function of T and natural killer (NK) cells and promoting thereby tumor progression. Furthermore, TEV can augment MDSC immunosuppressive capacity. Different subsets of mature myeloid cells such as monocytes, macrophages, dendritic cells (DC) and granulocytes take up TEV and acquire a protumorigenic phenotype. However, the delivery of tumor antigens to DC by TEV was shown to enhance their immunostimulatory capacity. The present review will discuss a diverse and complex EV-mediated crosstalk between tumor and myeloid cells in the context of the tumor type, TEV-associated cargo molecules and type of recipient cells.

Crosstalk between extracellular vesicles and tumor-associated macrophage in the tumor microenvironment

Extracellular vesicle-mediated crosstalk in tumor microenvironment dominates tumor fate

Tumor Cell-derived Extracellular Vesicles in Modulating Phenotypes and Immune Functions of Macrophages: Mechanisms and Therapeutic Applications.

Exosomes: A Potential Therapeutic Tool Targeting Communications Between Tumor Cells and Macrophages.

Extracellular vesicle-orchestrated crosstalk between cancer-associated fibroblasts and tumors

Tumor-Derived Extracellular Vesicles: A Means of Co-opting Macrophage Polarization in the Tumor Microenvironment

Small Extracellular Vesicles-Mediated Cellular Interactions Between Tumor Cells and Tumor-Associated Macrophages: Implication for Immunotherapy.

Extracellular vesicles in the tumor microenvironment: Therapeutic resistance, clinical biomarkers, and targeting strategies

Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment Are Essential Local and Long-Distance Mediators of Cancer Metastasis

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Tumor endothelial cell-derived extracellular vesicles contribute to tumor microenvironment remodeling

Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment

Tumor Hijacks Macrophages and Microbiota Through Extracellular Vesicles

The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response

Extracellular vesicles in the tumor immune microenvironment

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles

Exosome-Mediated Crosstalk Between Tumor and Tumor-Associated Macrophages

Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination

Roles of M1 Macrophages and Their Extracellular Vesicles in Cancer Therapy